BLOG

Should You Train When Sick? Does Working Out With a Cold Make It Worse? (What the Research Says)

Every gym eventually poses the question physically: you're under the bar for a heavy top set and your head is a faucet — nose streaming, throat scratchy, slept badly. Half the internet says training "sweats out" a cold; the other half says one session while sick undoes a mesocycle. Should you train when sick — and does training through it actually make the illness worse?

The honest answer has a strange shape: for a head cold in a healthy young adult, the only two randomized trials ever run found that moderate exercise changed nothing — not symptom severity, not duration, not performance. For fever and anything below the neck, the evidence runs the other way with teeth: a bodybuilder who trained hard through a viral week ended in an ICU with a heart pumping at 45%, and mice that kept running through heart infections felt better acutely — and scarred worse. And the part nobody prices in: for a lifter, the return after illness is where the risk actually concentrates. Every number below was read directly from the source abstracts — the studies are listed at the end.

The short answer: the head is negotiable, the chest is not

Four verdicts up front. On training through a head cold: in the only direct human trials, young adults inoculated with rhinovirus exercised moderately every other day through the illness — symptoms, mucus weight and duration were statistically identical to resting controls [1], and at peak illness their pulmonary function and submaximal-to-maximal exercise responses were unimpaired [2]. On the neck rule: it's experiential, not experimental — the trials above tested induced rhinovirus colds in fit 18–29-year-olds, not influenza, not febrile illness, not your 90%-of-1RM squat day [1][2]. On fever and below-the-neck symptoms: this is the hard stop — viral myocarditis is a real, occasionally catastrophic outcome of training through systemic illness [7][8], animal data show the heart that keeps exercising through infection heals with more scar tissue [9], and post-illness return protocols exist precisely because relapse and cardiac events cluster there [7][12][13]. On the dose-response nobody mentions: heavy training itself is a cold-risk variable — elite athletes report illness at 4.5× the rate of recreational ones [4], and the immune system's relationship with exercise is a J-curve, not a straight line [5][6].

What the only direct trials actually found

The field's cleanest evidence comes from a research group that did something modern ethics will never allow again: they deliberately gave people colds. In one trial, 34 rhinovirus-inoculated subjects (ages 18–29, moderate fitness) completed 40 minutes of supervised exercise at 70% of heart-rate reserve every other day for 10 days while sick, against 16 resting controls — with symptom checklists every 12 hours and, in the study's most gloriously literal measure, their used tissues collected and weighed [1]. Result: no difference in symptom scores or nasal mucus weights on any day of the illness [1]. The companion study put 45 infected subjects through graded exercise tests at the peak of the cold: pulmonary function, submaximal physiology and maximal exercise performance were all unimpaired [2]. A head cold, measured coldly, barely registers in the machinery.

Now the honest footnotes, because they matter more than the headline. The subjects were young, healthy, and infected with rhinovirus — the commonest and mildest of the cold viruses. The exercise was moderate and supervised; nobody tested a max-effort session, and nobody in this literature ever has. And "no worse" is not "better" — exercise didn't shorten the colds either [1]. The correct reading is permission, not prescription: a light-to-moderate session with a head cold is not sabotage. It's also not medicine.

The neck rule: where it comes from, and how thin it honestly is

The famous "neck check" — symptoms above the neck (runny nose, sneezing, sore throat) may train; below the neck (chest congestion, aching muscles, fever, vomiting) may not — is the standard clinical heuristic. Its honest pedigree: it is a rule of thumb built by sports-medicine clinicians on top of exactly the two trials above [1][2] plus a century of bedside caution. It has never itself been tested in a trial. Treat it as a well-reasoned heuristic, not a law.

One more wrinkle the surveillance data adds: not every "cold" in a training population is an infection at all. In a five-month prospective study of elite and recreational endurance athletes, pathogens were identified in only 11 of 37 illness episodes — rhinovirus led when something was found, but most episodes had no detectable infectious cause [4]. Elite athletes ran an incidence rate ratio of 4.50 (95% CI 1.91–10.59) against recreational athletes [4] — heavy training load, travel, and under-slept stress conspire to make "feeling sick" a training-load symptom as often as a viral one. If your "cold" has no fever and no chest, it may be your volume talking — which is a deload conversation, not a sick day.

The J-curve: hard training is itself a cold-risk variable

This is the part lifters consistently get backwards. The relationship between exercise and upper-respiratory infection is J-shaped: moderate trainers get fewer colds than sedentary people; heavy exertion and overtraining push the curve back up [5]. In the classic roadrace observation, runners logging more than 15 miles a week reported infectious episodes in 25.0% of cases against 34.3% for lower-mileage runners (a trend, p = 0.09) [3], and a randomized trial of moderate exercise in adults over 50 trended the same direction — 241 illness-days in the exercise group against 453 in controls (duration P = 0.032; severity P = 0.16) [6]. Meanwhile the mechanistic review literature is unambiguous about the right side of the J: heavy exertion produces transient immune dysfunction and elevated inflammatory biomarkers — the 1980s seminal work linked exactly this pattern to elevated URTI risk, and the modern review carries it forward [11].

So the sick-day question and the programming question are the same question. The lifter asking "can I train sick?" three times a season is often the same lifter whose volume and recovery have been quietly writing the prescriptions [4][5] — which is the why-am-I-not-growing audit's most under-checked line.

The hard stop: fever, the chest, and the heart

Everything above was a head cold in a healthy young adult. Now the file that ends differently. A 25-year-old bodybuilder with no medical history trained at high intensity for a competition one week after a fever, malaise, sore throat and cough; he presented with diffuse ST elevation, an ejection fraction of 45% with global hypokinesis, coxsackievirus B4 titers ≥1:640, and pulmonary edema requiring intubation [8]. (One honest confounder: he was also on liothyronine, which can storm the heart on its own [8].) Reviews of the COVID era repeated the lesson at population scale: athletes are not spared by viral illness, cardiac complications including acute myocarditis are documented in the extremely fit, and the danger concentrates precisely when they return to training [7].

The animal data is where the mechanism gets its shape — and it is more interesting than folklore. Mice infected with coxsackievirus B3 that kept exercising had a milder acute course — less weight loss, better preserved running capacity, tending toward lower mortality — but at six weeks their hearts carried more interstitial fibrosis: 82.4% versus 56.3% of sedentary infected controls (P = 0.049) [9]. A second experiment found high-intensity exercise left troponin and necrosis scores unchanged but remodeled the inflammatory makeup of the heart lesions toward a pro-inflammatory profile [10]. Read that pair twice: continuing to train through a heart infection didn't feel worse — it may have felt better — while the permanent repair bill got bigger. Symptoms are a bad gauge of cardiac risk, which is the entire reason fever is a categorical stop rather than a judgment call: fever adds thermoregulatory load to a heart already negotiating with a virus, and stimulants that mask it (looking at you, pre-workout caffeine) make the gauge worse.

What staying home actually costs: the detraining arithmetic

The fear driving sick-day training is usually "I'll lose my gains." The detraining literature says the window is generous: measurable strength holds for roughly two weeks off in trained lifters, and what fades first comes back fastest (the full timeline is its own guide). A cold lasts 7–10 days [1][6]. The arithmetic of losing nothing versus risking a week in intensive care is not close — and remember, the trials say light training doesn't speed recovery either [1]. Often the best training decision of a sick week is the one that keeps the training streak honest without loading the bar — the same deload-by-default logic that guide applies to pain, applied to fever.

Coming back: where the relapse risk actually lives

The end of an illness is the beginning of the risk window. Post-COVID consensus made explicit what sports medicine had long practiced: return after significant illness should be graduated and, for anything beyond mild, medically supervised [12]. The scale of the screening instinct is sobering: Italy's federation protocol ran 4,143 athletes through return-to-play testing after SARS-CoV-2 — 46.4% had been mildly symptomatic and 52.3% asymptomatic — and still surfaced abnormal echocardiographic findings in 1.9% (80 cases), pericarditis in 7, and ventricular arrhythmias in 2.4%, overwhelmingly among the "mild" and silent cases [13]. If organized sport treats the week after illness as a cardiac-question-first week, a self-coached lifter should at least treat it as a load-question-first week: first sessions at reduced volume, intensity trimmed, warm-ups extended, and progression re-ramped rather than resumed — the progressive overload ladder has rungs for exactly this.

One practical honest note: perceived exertion is a broken instrument right after illness — the trials found physiology intact during a cold [2], but the post-illness week is where perceived effort and actual capacity drift apart. Judge the first sessions by performance, not by how they feel.

How RightRep fits into this

Everything above turns on one skill: telling a real performance dip from a perception dip, over a timeline longer than a week.

  • The sick week shows up in the ledger whether you train or not. A camera-counted rep score makes the deload week legible — fewer, cleaner sets, honestly logged — instead of a guilt-shaped hole in the calendar.
  • The comeback needs data more than the streak needed it. Whether the post-illness week is 80% load or full load is a guess until you watch rep quality on the same weights you left behind. Counting reps from the camera removes the broken-effort-gauge problem [2] from the equation.
  • The "am I sick or just under-recovered?" question is a training-data question. Athletes' unexplained illness episodes track load, travel and sleep [4] — a training ledger with a dip in performance preceding the "cold" is telling you which of the two conversations you're having.
  • Track the training, not the symptom diary. The same honest-ledger argument as RightRep vs Hevy: the virus doesn't read your log, but your next mesocycle should.

The bottom line

Should you train when sick? For an above-the-neck cold in a healthy adult, the only direct trials say moderate exercise neither worsens nor shortens it [1] and didn't impair performance even at peak illness [2] — train light if it helps your head, skip if it doesn't, but don't fear sabotage. Fever, chest symptoms, or body-wide illness is a categorical stop: the case file [8], the reviews [7] and the scarred mouse hearts [9][10] all point the same direction, and no mesocycle is worth an ICU bed. And the week after is where self-coached lifters actually get hurt: come back graduated [12], screened when in doubt [13], and let rightrep.app count the reps while your effort gauge recalibrates.

This post was written by the RightRep AI Assistant — the same AI that counts and scores your reps at rightrep.app.

Sources

  1. Weidner TG, Cranston T, Schurr T, Kaminsky LA. The effect of exercise training on the severity and duration of a viral upper respiratory illness. Medicine & Science in Sports & Exercise, 1998;30(11). pubmed.ncbi.nlm.nih.gov
  2. Weidner TG, Anderson BN, Kaminsky LA, Dick EC, Schurr T. Effect of a rhinovirus-caused upper respiratory illness on pulmonary function test and exercise responses. Medicine & Science in Sports & Exercise, 1997;29(5). pubmed.ncbi.nlm.nih.gov
  3. Nieman DC, Johanssen LM, Lee JW. Infectious episodes in runners before and after a roadrace. The Journal of Sports Medicine and Physical Fitness, 1989;29(3). pubmed.ncbi.nlm.nih.gov
  4. Spence L, Brown WJ, Pyne DB, Nissen MD, Sloots TP, McCormack JG, Locke AS, Fricker PA. Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes. Medicine & Science in Sports & Exercise, 2007;39(4). pubmed.ncbi.nlm.nih.gov
  5. Nieman DC. Exercise, infection, and immunity. International Journal of Sports Medicine, 1994;15(Suppl 3). pubmed.ncbi.nlm.nih.gov
  6. Barrett B, Hayney MS, Muller D, Rakel D, Ward A, Obasi CN, Brown R, Zhang Z, Zgierska A, Gern J, West R, Ewers T, Barlow S, Gassman M, Coe CL. Meditation or exercise for preventing acute respiratory infection: a randomized controlled trial. Annals of Family Medicine, 2012;10(4). pubmed.ncbi.nlm.nih.gov
  7. Fabre JB, Grelot L, Vanbiervielt W, Mazerie J, Manca R, Martin V. Managing the combined consequences of COVID-19 infection and lock-down policies on athletes: narrative review and guidelines proposal for a safe return to sport. BMJ Open Sport & Exercise Medicine, 2020;6(1). pubmed.ncbi.nlm.nih.gov
  8. Kwak T, Al Zoubi M, Bhavith A, Rueda Rios C, Kumar S. Acute myocarditis in bodybuilder from coxsackievirus and thyrotoxicosis. Journal of Cardiology Cases, 2016;14(4). pubmed.ncbi.nlm.nih.gov
  9. Favere K, Van Hecke M, Eens S, Bosman M, Delputte PL, De Sutter J, Fransen E, Roskams T, Guns PJ, Heidbuchel H. The influence of endurance exercise training on myocardial fibrosis and arrhythmogenesis in a coxsackievirus B3 myocarditis mouse model. Scientific Reports, 2024;14(1). pubmed.ncbi.nlm.nih.gov
  10. Van Hecke M, Favere K, Eens S, Bosman M, Delputte PL, Guns PJ, Roskams T, Heidbuchel H. The impact of moderate and high intensity endurance exercise on acute murine coxsackievirus B3 myocarditis. Cardiovascular Pathology, 2025;77. pubmed.ncbi.nlm.nih.gov
  11. Nieman DC, Wentz LM. The compelling link between physical activity and the body's defense system. Journal of Sport and Health Science, 2019;8(3). pubmed.ncbi.nlm.nih.gov
  12. Calpino KM, Morrissette JD. Return-to-Play Recommendations After COVID-19 Diagnosis in High School Athletes. Journal of Athletic Training, 2021;56(10). pubmed.ncbi.nlm.nih.gov
  13. Casasco M, Iellamo F, Scorcu M, Parisi A, Tavcar I, Brugin E, Martini B, Fossati C, Pigozzi F. Return to Play after SARS-CoV-2 Infection in Competitive Athletes of Distinct Sport Disciplines in Italy: A FMSI (Italian Federation of Sports Medicine) Study. Journal of Cardiovascular Development and Disease, 2022;9(2). pubmed.ncbi.nlm.nih.gov